Patent · US Active

Targeted RNA knockdown and knockout by type III-A Csm complexes

US11274317B2 · kind B2 · utility

5Cited by
1References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 31, 2017
Grant dateMar 15, 2022
Priority date—
Expiry dateJul 20, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2320/30
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Methods and compositions using a CRISPR-Cas Type IIIA resulting in RNA gene knockdown and knockout in an animal.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.